Beacon Harbor Wealth Advisors, Inc. Amgen Inc Transaction History

Beacon Harbor Wealth Advisors, Inc.

$422 Million
Q1 2025

A detailed history of Beacon Harbor Wealth Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Beacon Harbor Wealth Advisors, Inc. holds 26,902 shares of AMGN stock, worth $8.25 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares

26,902

Previous 13,548 98.57%

Holding current value

$8.25 Million

Previous $3.53 Million 137.35%

% of portfolio

1.99%

Previous 0.87%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$258.59 - $327.36 $3.45 Million - $4.37 Million	13,354 Added 98.57%	26,902 $8.38 Million
Q4 2024 Feb 06, 2025	BUY	$258.78 - $328.31 $3.51 Million - $4.45 Million	13,548 New	13,548 $3.53 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $232,687 - $262,498	-910 Reduced 6.55%	12,993 $3.74 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $1.82 Million - $2.27 Million	-8,345 Reduced 37.51%	13,903 $3.74 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $263,980 - $312,151	1,232 Added 5.86%	22,248 $4.94 Million
Q1 2023 Apr 28, 2023	SELL	$225.79 - $275.2 $38,384 - $46,784	-170 Reduced 0.8%	21,016 $5.08 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $690,296 - $877,104	-3,014 Reduced 12.45%	21,186 $5.56 Million
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $55,370 - $61,617	-240 Reduced 0.98%	24,200 $5.89 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $5.36 Million - $5.93 Million	24,440 New	24,440 $5.91 Million

Others Institutions Holding AMGN

# of Institutions

3,285

Shares Held

426M

Call Options Held

8.07M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Harbor Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beacon Harbor Wealth Advisors, Inc. with notifications on news.

Account

Beacon Harbor Wealth Advisors, Inc. Amgen Inc Transaction History